ArticleCell death & disease2018

Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant.

Bei Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.